MedTrace Logo

Genetic Testing for Type 2 Diabetes

NCT01060540 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 601

Last updated 2015-04-24

Study results available
· View outcomes & findings →

Summary

In this 6-month randomized, controlled trial, we examined whether providing participants with genetic test results and counseling regarding their risk for type 2 diabetes would motivate them to improve their health behaviors and lose weight to reduce their diabetes risk. We hypothesized that participants who received conventional diabetes counseling plus genetic test results and counseling would have at least 6 lb greater weight loss at 3 months than participants who received conventional diabetes counseling without genetic test results.

Conditions

Interventions

GENETIC

genetic testing for type 2 diabetes

TCF7L2, PPARG, or KCNJ11

BEHAVIORAL

Conventional risk counseling

Risk based on lifetime risk, fasting plasma glucose results, and family history.

BEHAVIORAL

eye disease counseling

addresses risk for age-related macular degeneration, glaucoma, cataracts

Sponsors & Collaborators

Principal Investigators

  • Corrine I. Voils, PhD · Durham VA Medical Center, Durham, NC

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01060540 on ClinicalTrials.gov